{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:38:24Z","timestamp":1787841504519,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12282-026-01898-5","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:44:09Z","timestamp":1784879049000},"page":"1183-1193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BARD1 and breast cancer genetic predisposition: case\u2013control study and HRD signature analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Marie-Florence","family":"Reveneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Masliah-Planchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Decees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Lakhlifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Pasanisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Le","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Pag\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Pierre-No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molka","family":"Sebai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine M.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Moncoutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Tenreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Berthemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Carri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dubois d\u2019Enghien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Abidallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Zaguia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs Curto","family":"Taribo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa Trabelsi","family":"Grati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonore","family":"Frouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e9vin","family":"Merchadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Quinquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Filser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Delhomelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Le Mentec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Warcoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Charlotte","family":"Villy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Saule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Mouret-Fourme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gauthier-Villars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Buecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Henri","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pasmant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystelle","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Golmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"9","key":"1898_CR1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424 . (PubMed PMID: 28418444; PubMed Central PMCID: PMC5599323).","journal-title":"JAMA Oncol 1 sept"},{"key":"1898_CR2","doi-asserted-by":"publisher","unstructured":"Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C et al. Breast cancer risk genes\u2014association analysis in more than 113,000 women. N Engl J Med. 2021;384(5):428\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1913948. (PubMed PMID: 33471991; PubMed Central PMCID: PMC7611105).","DOI":"10.1056\/NEJMoa1913948"},{"issue":"9","key":"1898_CR3","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","volume":"55","author":"N Wilcox","year":"2023","unstructured":"Wilcox N, Dumont M, Gonz\u00e1lez-Neira A, Carvalho S, Joly Beauparlant C, Crotti M, et al. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Nat Genet. 2023;55(9):1435\u20139. https:\/\/doi.org\/10.1038\/s41588-023-01466-z.","journal-title":"Nat Genet sept"},{"issue":"1","key":"1898_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-019-1137-9","volume":"21","author":"N Weber-Lassalle","year":"2019","unstructured":"Weber-Lassalle N, Borde J, Weber-Lassalle K, Horv\u00e1th J, Niederacher D, Arnold N, et al. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast Cancer Res BCR. 2019;21(1):55. https:\/\/doi.org\/10.1186\/s13058-019-1137-9 . (PubMed PMID: 31036035; PubMed Central PMCID: PMC6489184).","journal-title":"Breast Cancer Res BCR 29 avr"},{"issue":"12","key":"1898_CR5","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41436-018-0005-9","volume":"20","author":"L Cast\u00e9ra","year":"2018","unstructured":"Cast\u00e9ra L, Harter V, Muller E, Krieger S, Goardon N, Ricou A, et al. Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. Genet Med Off J Am Coll Med Genet. 2018;20(12):1677\u201386. https:\/\/doi.org\/10.1038\/s41436-018-0005-9. (PubMed PMID: 29988077).","journal-title":"Genet Med Off J Am Coll Med Genet d\u00e9c"},{"issue":"1","key":"1898_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2018.2956","volume":"5","author":"HM Lu","year":"2019","unstructured":"Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, et al. Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing. JAMA Oncol. 2019;5(1):51\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2956. (PubMed PMID: 30128536; PubMed Central PMCID: PMC6439764).","journal-title":"JAMA Oncol 1 janv"},{"issue":"2","key":"1898_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/genes12020150","volume":"12","author":"P Rofes","year":"2021","unstructured":"Rofes P, Del Valle J, Torres-Esquius S, Feliubadal\u00f3 L, Stradella A, Moreno-Cabrera JM, et al. BARD1 pathogenic variants are associated with triple-negative breast cancer in a Spanish hereditary breast and ovarian cancer cohort. Genes. 2021;12(2):150. https:\/\/doi.org\/10.3390\/genes12020150. (PubMed PMID: 33498765; PubMed Central PMCID: PMC7911518).","journal-title":"Genes 23 janv"},{"issue":"12","key":"1898_CR8","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jmedgenet-2022-108471","volume":"59","author":"A Lee","year":"2022","unstructured":"Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. J Med Genet. 2022;59(12):1206\u201318. https:\/\/doi.org\/10.1136\/jmedgenet-2022-108471. (PubMed PMID: 36162851; PubMed Central PMCID: PMC9691826).","journal-title":"J Med Genet d\u00e9c"},{"issue":"1","key":"1898_CR9","doi-asserted-by":"publisher","first-page":"8536","DOI":"10.1038\/s41598-023-35755-8","volume":"13","author":"NB M\u00f8ller","year":"2023","unstructured":"M\u00f8ller NB, Boonen DS, Feldner ES, Hao Q, Larsen M, L\u00e6nkholm AV, et al. Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. Sci Rep. 2023;13(1):8536. https:\/\/doi.org\/10.1038\/s41598-023-35755-8. (PubMed PMID: 37237042; PubMed Central PMCID: PMC10220031).","journal-title":"Sci Rep 26 mai"},{"issue":"4","key":"1898_CR10","doi-asserted-by":"publisher","first-page":"a004093","DOI":"10.1101\/mcs.a004093","volume":"5","author":"MR Toh","year":"2019","unstructured":"Toh MR, Chong ST, Chan SH, Low CE, Ishak NDB, Lim JQ, et al. Functional analysis of clinical BARD1 germline variants. Mol Case Stud. 2019;5(4):a004093. https:\/\/doi.org\/10.1101\/mcs.a004093.","journal-title":"Mol Case Stud ao\u00fbt"},{"issue":"7","key":"1898_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/genes11070798","volume":"11","author":"M Suszynska","year":"2020","unstructured":"Suszynska M, Kozlowski P. Summary of BARD1 Mutations and precise estimation of breast and ovarian cancer risks associated with the mutations. Genes. 2020;11(7):798. https:\/\/doi.org\/10.3390\/genes11070798. (PubMed PMID: 32679805; PubMed Central PMCID: PMC7397132).","journal-title":"Genes 15 juill"},{"issue":"12","key":"1898_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/gcc.20822","volume":"49","author":"R Sabatier","year":"2010","unstructured":"Sabatier R, Ad\u00e9la\u00efde J, Finetti P, Ferrari A, Huiart L, Sobol H, et al. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer. Genes Chromosomes Cancer. 2010;49(12):1143\u201351. https:\/\/doi.org\/10.1002\/gcc.20822. (PubMed PMID: 20842729).","journal-title":"Genes Chromosomes Cancer d\u00e9c"},{"issue":"2","key":"1898_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jnci\/djac","volume":"115","author":"BWX Lim","year":"2023","unstructured":"Lim BWX, Li N, Mahale S, McInerny S, Zethoven M, Rowley SM, et al. Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. J Natl Cancer Inst. 2023;115(2):181\u20139. https:\/\/doi.org\/10.1093\/jnci\/djac196. (PubMed PMID: 36315097; PubMed Central PMCID: PMC9905963).","journal-title":"J Natl Cancer Inst 8 f\u00e9vr"},{"issue":"1","key":"1898_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21519-3","volume":"12","author":"W Li","year":"2021","unstructured":"Li W, Gu X, Liu C, Shi Y, Wang P, Zhang N, et al. A synergetic effect of BARD1 mutations on tumorigenesis. Nat Commun. 2021;12(1):1. https:\/\/doi.org\/10.1038\/s41467-021-21519-3.","journal-title":"Nat Commun 23 f\u00e9vr"},{"issue":"4","key":"1898_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ijc.29829","volume":"138","author":"E Mani\u00e9","year":"2016","unstructured":"Mani\u00e9 E, Popova T, Battistella A, Tarabeux J, Caux-Moncoutier V, Golmard L, et al. Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas. Int J Cancer. 2016;138(4):891\u2013900. https:\/\/doi.org\/10.1002\/ijc.29829. (PubMed PMID: 26317927).","journal-title":"Int J Cancer 15 f\u00e9vr"},{"issue":"7","key":"1898_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJMc2403316","volume":"391","author":"M Cupit-Link","year":"2024","unstructured":"Cupit-Link M, Hagiwara K, Nagy M, Koo SC, Orr BA, Ruppin E, et al. Response to PARP Inhibition in BARD1 -mutated refractory neuroblastoma. N Engl J Med. 2024;391(7):659\u201361. https:\/\/doi.org\/10.1056\/NEJMc2403316.","journal-title":"N Engl J Med 15 ao\u00fbt"},{"issue":"1","key":"1898_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41698-022-00291-7","volume":"6","author":"KM Dillon","year":"2022","unstructured":"Dillon KM, Bekele RT, Sztupinszki Z, Hanlon T, Rafiei S, Szallasi Z, et al. PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer. NPJ Precis Oncol. 2022;6(1):49. https:\/\/doi.org\/10.1038\/s41698-022-00291-7. (PubMed PMID: 35768576; PubMed Central PMCID: PMC9242979).","journal-title":"NPJ Precis Oncol 29 juin"},{"key":"1898_CR18","doi-asserted-by":"publisher","unstructured":"Randall MP, Egolf LE, Vaksman Z, Samanta M, Tsang M, Groff D, et al. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. JNCI J Natl Cancer Inst 9 sept. 2023;djad182. https:\/\/doi.org\/10.1093\/jnci\/djad182.","DOI":"10.1093\/jnci\/djad182"},{"key":"1898_CR19","unstructured":"INCa. Les pr\u00e9dispositions g\u00e9n\u00e9tiques - Oncog\u00e9n\u00e9tique et plateformes de g\u00e9n\u00e9tique mol\u00e9culaire. [cit\u00e9 29 ao\u00fbt 2023]. https:\/\/www.e-cancer.fr\/Professionnels-de-sante\/L-organisation-de-l-offre-de-soins\/Oncogenetique-et-plateformes-de-genetique-moleculaire\/Les-predispositions-genetiques"},{"key":"1898_CR20","doi-asserted-by":"publisher","unstructured":"Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, et al. Recommandations fran\u00e7aises du Groupe G\u00e9n\u00e9tique et Cancer pour l\u2019analyse en panel de g\u00e8nes dans les pr\u00e9dispositions h\u00e9r\u00e9ditaires au cancer du sein ou de l\u2019ovaire. Bull Cancer (Paris). 2018;1(10):907\u201317. https:\/\/doi.org\/10.1016\/j.bulcan.2018.08.003.","DOI":"10.1016\/j.bulcan.2018.08.003"},{"issue":"5","key":"1898_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet mai. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30. (PubMed PMID: 25741868; PubMed Central PMCID: PMC4544753).","journal-title":"Genet Med Off J Am Coll Med Genet mai"},{"key":"1898_CR22","doi-asserted-by":"publisher","unstructured":"Leman R, Parfait B, Vidaud D, Girodon E, Pacot L, Le Gac G, et al. SPiP: Splicing prediction pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing. Hum Mutat. 2022;43(12):2308\u201323. https:\/\/doi.org\/10.1002\/humu.24491(PubMed PMID: 36273432; PubMed Central PMCID: PMC10946553).","DOI":"10.1002\/humu.24491"},{"issue":"3","key":"1898_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Panagiotopoulou SK, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535\u2013e54824. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015. (PubMed PMID: 30661751).","journal-title":"Cell 24 janv"},{"issue":"12","key":"1898_CR24","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1093\/bioinformatics\/btaa261","volume":"36","author":"A Eeckhoutte","year":"2020","unstructured":"Eeckhoutte A, Houy A, Mani\u00e9 E, Reverdy M, Bi\u00e8che I, Marangoni E, et al. ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing. Bioinforma Oxf Engl. 2020;36(12):3888\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa261. (PubMed PMID: 32315385; PubMed Central PMCID: PMC7320600).","journal-title":"Bioinforma Oxf Engl 1 juin"},{"issue":"1","key":"1898_CR25","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/s41467-023-37537-2","volume":"14","author":"P ter Brugge","year":"2023","unstructured":"Ter Brugge P, Moser SC, Bi\u00e8che I, Kristel P, Ibadioune S, Eeckhoutte A, et al. Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers. Nat Commun. 2023;14(1):1958. https:\/\/doi.org\/10.1038\/s41467-023-37537-2(PubMed PMID: 36273432; PubMedCentral PMCID: PMC10946553).","journal-title":"Nat Commun 7 avr"},{"key":"1898_CR26","doi-asserted-by":"publisher","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497\u2013506. https:\/\/doi.org\/10.1056\/NEJMoa1400382. (PubMed PMID: 25099575; PubMed Central PMCID: PMC4157599).","DOI":"10.1056\/NEJMoa1400382"},{"key":"1898_CR27","doi-asserted-by":"publisher","unstructured":"Almansour NM. Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence. Front Mol Biosci. 2022;9:836417. https:\/\/doi.org\/10.3389\/fmolb.2022.836417. (PubMed PMID: 35145999; PubMed Central PMCID: PMC8824427).","DOI":"10.3389\/fmolb.2022.836417"},{"issue":"3","key":"1898_CR28","doi-asserted-by":"publisher","first-page":"e216744","DOI":"10.1001\/jamaoncol.2021.6744","volume":"8","author":"N Mavaddat","year":"2022","unstructured":"Breast Cancer Association Consortium, Mavaddat N, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, et al. Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes. JAMA Oncol. 2022;8(3):e216744. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6744. (PubMed PMID: 35084436; PubMed Central PMCID: PMC8796069).","journal-title":"JAMA Oncol 1 mars"},{"issue":"11","key":"1898_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41588-021-00949-1","volume":"53","author":"P Srinivasan","year":"2021","unstructured":"Srinivasan P, Bandlamudi C, Jonsson P, Kemel Y, Chavan SS, Richards AL, et al. The context-specific role of germline pathogenicity in tumorigenesis. Nat Genet. 2021;53(11):11. https:\/\/doi.org\/10.1038\/s41588-021-00949-1.","journal-title":"Nat Genet nov"},{"issue":"12","key":"1898_CR30","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1158\/1078-0432.CCR-10-2900","volume":"17","author":"H Makishima","year":"2011","unstructured":"Makishima H, Maciejewski JP. Pathogenesis and consequences of uniparental disomy in cancer. Clin Cancer Res. 2011;17(12):3913\u201323. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2900.","journal-title":"Clin Cancer Res 15 juin"},{"issue":"10","key":"1898_CR31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-019-0582-4","volume":"25","author":"J Staaf","year":"2019","unstructured":"Staaf J, Glodzik D, Bosch A, Vallon-Christersson J, Reutersw\u00e4rd C, H\u00e4kkinen J, et al. Whole-genome-sequencing of triple negative breast cancers in a population-based clinical study. Nat Med. 2019;25(10):1526\u201333. https:\/\/doi.org\/10.1038\/s41591-019-0582-4. (PubMed PMID: 31570822; PubMed Central PMCID: PMC6859071).","journal-title":"Nat Med oct"},{"key":"1898_CR32","doi-asserted-by":"publisher","unstructured":"Tuna M, Smid M, Zhu D, Martens JWM, Amos CI. Association between acquired uniparental disomy and homozygous mutations and HER2\/ER\/PR status in breast cancer. PLoS ONE. 2010;30(11):e15094. https:\/\/doi.org\/10.1371\/journal.pone.0015094.","DOI":"10.1371\/journal.pone.0015094"},{"key":"1898_CR33","doi-asserted-by":"publisher","unstructured":"Inagaki-Kawata Y, Yoshida K, Kawaguchi-Sakita N, Kawashima M, Nishimura T, Senda N, et al. Genetic and clinical landscape of breast cancers with germline BRCA1\/2 variants. Commun Biol. 2020;16(1):578. https:\/\/doi.org\/10.1038\/s42003-020-01301-9.","DOI":"10.1038\/s42003-020-01301-9"},{"key":"1898_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41467-017-00388-9","volume":"8","author":"KN Maxwell","year":"2017","unstructured":"Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, et al. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. Nat Commun. 2017;8:319. https:\/\/doi.org\/10.1038\/s41467-017-00388-9. (PubMed PMID: 28831036; PubMed Central PMCID: PMC5567274).","journal-title":"Nat Commun 22 ao\u00fbt"},{"issue":"12","key":"1898_CR35","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1016\/j.celrep.2018.02.095","volume":"22","author":"JF Knight","year":"2018","unstructured":"Knight JF, Sung VYC, Kuzmin E, Couzens AL, de Verteuil DA, Ratcliffe CDH, et al. KIBRA (WWC1) Is a metastasis suppressor gene affected by chromosome 5q loss in triple-negative breast cancer. Cell Rep. 2018;22(12):3191\u2013205. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.095. (PubMed PMID: 29562176; PubMed Central PMCID: PMC5873529).","journal-title":"Cell Rep 20 mars"},{"issue":"1","key":"1898_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/BD-210047","volume":"41","author":"IA Voutsadakis","year":"2022","unstructured":"Voutsadakis IA. Loss of genes in chromosome arms 5q and 16q in breast cancer. Breast Dis. 2022;41(1):331\u201341. https:\/\/doi.org\/10.3233\/BD-210047. (PubMed PMID: 35964165).","journal-title":"Breast Dis"},{"issue":"6","key":"1898_CR37","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1007\/s12282-025-01740-4","volume":"32","author":"R Semba","year":"2025","unstructured":"Semba R, Eguchi H, Takatsu M, Hashizume T, Moteki H, Maeno K, et al. Two-hit events occurred independently in bilateral breast cancers in a germline double heterozygous carrier for BRCA1 and BRCA2. Breast Cancer. 2025;32(6):1472\u20139. https:\/\/doi.org\/10.1007\/s12282-025-01740-4. (PubMed PMID: 40601170; PubMed Central PMCID: PMC12552342).","journal-title":"Breast Cancer nov"},{"issue":"36","key":"1898_CR38","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1200\/JCO.20.02151","volume":"38","author":"NM Tung","year":"2020","unstructured":"Tung NM, Robson ME, Ventz S, Santa-Maria CA, Nanda R, Marcom PK, et al. TBCRC 048: Phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(36):4274\u201382. https:\/\/doi.org\/10.1200\/JCO.20.02151 . (PubMed PMID: 33119476).","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol 20 d\u00e9c"},{"issue":"2","key":"1898_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/hmg\/7.2.195","volume":"7","author":"T Thai","year":"1998","unstructured":"Thai T. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum Mol Genet. 1998;7(2):195\u2013202. https:\/\/doi.org\/10.1093\/hmg\/7.2.195.","journal-title":"Hum Mol Genet 1 f\u00e9vr"},{"issue":"4","key":"1898_CR40","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci. 1971;68(4):820\u20133. https:\/\/doi.org\/10.1073\/pnas.68.4.820. (PubMed PMID: 5279523; PubMed Central PMCID: PMC389051).","journal-title":"Proc Natl Acad Sci U S avr"},{"key":"1898_CR41","first-page":"83","volume":"118","author":"K Inoue","year":"2017","unstructured":"Inoue K, Fry EA. Haploinsufficient tumor suppressor genes. Adv Med Biol. 2017;118:83\u2013122. (PubMed PMID: 28680740; PubMed Central PMCID: PMC5494974).","journal-title":"Adv Med Biol 1st Quart"},{"issue":"7766","key":"1898_CR42","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1363-4","volume":"571","author":"M Daza-Martin","year":"2019","unstructured":"Daza-Martin M, Starowicz K, Jamshad M, Tye S, Ronson GE, MacKay HL, et al. Isomerization of BRCA1\u2013BARD1 promotes replication fork protection. Nature. 2019;571(7766):521\u20137. https:\/\/doi.org\/10.1038\/s41586-019-1363-4.","journal-title":"Nat juill"},{"issue":"8","key":"1898_CR43","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, et al. Variant interpretation using population databases: lessons from gnomAD. Hum Mutat. 2022;43(8):1012\u201330. https:\/\/doi.org\/10.1002\/humu.24309. (PubMed PMID: 34859531; PubMed Central PMCID: PMC9160216).","journal-title":"Hum Mutat ao\u00fbt"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01898-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:58:28Z","timestamp":1787839108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01898-5","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An informed consent form was signed by all patients in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}